Edwards Lifesciences Corporation (EW) Q4 2008 Earnings Results

Edwards Lifesciences Beats on EPS, Stock Up 0.14%

Edwards Lifesciences reported a better-than-expected EPS, which contributed to a slight increase in their stock price. Investors may view the positive EPS surprise as a sign of resilience in the company's performance. However, the lack of revenue data and guidance leaves some uncertainty about future growth prospects.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.78	N/A	+2.63%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting their commitment to innovation. They emphasized the importance of addressing patient needs in their future strategies.

We are pleased with our EPS performance this quarter.

Our focus remains on innovation and meeting patient needs.

Edwards Lifesciences Beats on EPS, Stock Up 0.14%

Key numbers

Management commentary

Edwards Lifesciences Corporation

More earnings this week

Edwards Lifesciences Beats on EPS, Stock Up 0.14%

Key numbers

Management commentary